Copy number gain of ACTN4 is associated with poor prognosis in patients with upper urinary tract urothelial carcinoma

MLA

Kazuki Kawamura, et al. “Copy Number Gain of ACTN4 Is Associated with Poor Prognosis in Patients with Upper Urinary Tract Urothelial Carcinoma.” Cancer Science, May 2023. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........8c253bc0beceea1b9cbfd0faf922feb1&authtype=sso&custid=ns315887.

APA

Kazuki Kawamura, Kosuke Miyai, Kimiya Sato, Susumu Matsukuma, Kazufumi Honda, Keiichi Ito, & Hitoshi Tsuda. (2023). Copy number gain of ACTN4 is associated with poor prognosis in patients with upper urinary tract urothelial carcinoma. Cancer Science.

Chicago

Kazuki Kawamura, Kosuke Miyai, Kimiya Sato, Susumu Matsukuma, Kazufumi Honda, Keiichi Ito, and Hitoshi Tsuda. 2023. “Copy Number Gain of ACTN4 Is Associated with Poor Prognosis in Patients with Upper Urinary Tract Urothelial Carcinoma.” Cancer Science, May. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........8c253bc0beceea1b9cbfd0faf922feb1&authtype=sso&custid=ns315887.